Vitamin D3 and B12 supplementation in pregnancy.
Oral supplement
Pregnancy outcomes
Vitamin B12
Vitamin D3
Journal
Diabetes research and clinical practice
ISSN: 1872-8227
Titre abrégé: Diabetes Res Clin Pract
Pays: Ireland
ID NLM: 8508335
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
29
12
2020
revised:
08
02
2021
accepted:
12
02
2021
pubmed:
5
3
2021
medline:
29
5
2021
entrez:
4
3
2021
Statut:
ppublish
Résumé
To assess the efficacy of vitamin D3 or B12 supplementation during pregnancy. Pregnant women at 6-14 weeks in the intervention arm received oral high dose intermittent vitamin D3 and/or low dose B12 supplementation if they had vitamin D or vitamin B12 deficiency. The control arm received prescribed dietary instruction only. An additional observational arm for those mothers at booking with normal vitamin D and vitamin B12 level was also recruited. All groups received standard care during pregnancy. The primary endpoint of either vitamin D or B12 at term was not met. At baseline 25% participants in both the interventional and control arms had severe D deficiency (<30 nmol/l), reducing to under 3.4% in both groups. No maternal differences in vitamin D or B12 levels were found at delivery between the intervention, control, or observational groups. No significant difference in any of the pregnancy or birth outcomes was observed between three groups. In this study, oral supplementation of high dose intermittent vitamin D or low dose vitamin B12 regime failed to correct the relevant nutritional deficiencies in Bangladeshi pregnant women as per protocol. Both dietary supplementation and high dose vitamin D corrected severe vitamin deficiency.
Identifiants
pubmed: 33662489
pii: S0168-8227(21)00081-4
doi: 10.1016/j.diabres.2021.108728
pii:
doi:
Substances chimiques
Cholecalciferol
1C6V77QF41
Vitamin B 12
P6YC3EG204
Types de publication
Journal Article
Randomized Controlled Trial
Langues
eng
Sous-ensembles de citation
IM
Pagination
108728Informations de copyright
Copyright © 2021. Published by Elsevier B.V.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.